OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Prostate Cancer cDNA Array II

Be the first to review this product
SKU
HPRT502
TissueScan Prostate Cancer Tissue qPCR Panel II (10) containing ten identical sets of 48 tissues covering four disease stages, BPH and normal tissues
  $2,500.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Prostate Cancer cDNA Array II
Clinical Info
Diagnosis Category Prostate Cancer
Tissue Prostate
Shipping Ambient
Description TissueScan Prostate Cancer Tissue qPCR Panel II (10) containing ten identical sets of 48 tissues covering four disease stages, BPH and normal tissues
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc
Lin, Wang, Chen et al
Cancers (Basel) (2019) 11 (11) DOI: 10.3390/cancers11111785
AI Summary: OriGene's TissueScan Prostate Tissue qPCR Array (HPRT501~503) was used in this study to measure KDM4C mRNA levels across human prostate tissues and cancer stages, enabling the authors to correlate KDM4C expression with prostate cancer progression.
Snippet: The KDM4C mRNA level of human prostate tissue and different stages of prostate cancer were determined on TissueScan Prostate Tissue qPCR Array HPRT501~503 (OriGene Technologies, Rockville, MD, USA) according to the manufacturer’s instruction with Maxima SYBR Green/ROX qPCR Master Mix (2×) (Fermentas, Glen Burnie, MA, USA) and analyzed by ABI PRISM 7000 (Applied Biosystems/Life Technologies, Carlsbad, CA, USA). …
Elevated YKL40 is associated with advanced prostate cancer
Jeet, Tevz, Lehman et al
Endocr. Relat. Cancer (2014)
AI Summary: OriGene’s TissueScan qPCR arrays (HPRT502, HPRT503) were used to measure YKL40 mRNA expression in clinical prostate cancer and matched normal tissue samples, enabling the study to link elevated YKL40 levels with advanced prostate cancer.
Snippet: Page 8. 8 Evaluation of YKL40 Expression in PCa patients: 158 The human “Tissue Scan QPCR array” (HPRT502, HPRT503, Origene) was used for 159 determining the mRNA expression of YKL40 in clinical samples of matched normal prostate 160 and PCa tissues ... Cite SaveSaving
The renal handling of amphotericin B and amphotericin B/deoxycholate and potential renal drug-drug interactions with selected antivirals
Trejtnar, Mandíková, Kočíncová et al
Antimicrob. Agents Chemother. (2014)
AI Summary: OriGene products, specifically the human OAT1 (SLC22A6) expression plasmid (RC207579), human OCT2 (SLC22A2) expression plasmid (RC207921), and the pCMV6-Entry vector (PS100001), were used to transiently transfect HeLa and MDCK II cells for studying the role of renal transporters in the excretion and drug-drug interactions of amphotericin B and its prodrug.
Snippet: RC207579;human OCT2 (SLC22A2) expression plasmid, catalog number: RC207921 and 109 pCMV6-Entry vector (empty vector), catalog number: PS100001 were obtained from 110 OriGene Technologies (Rockville, USA). 111 HeLa cell culture. ... Cite SaveSaving
Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis
Lin, Cheng, Yang et al
Oncogene (2012) 31 (27), 3287-97 DOI: 10.1038/onc.2011.491
Cited by 52
AI Summary: OriGene’s TissueScan Cancer Survey Panels (CSRT101) and TissueScan Prostate Cancer quantitative PCR Panels (HPRT502) were used in this study to analyze BTG3 expression across various cancer tissues, helping to establish its downregulation in prostate cancer.
Snippet: qPCR was performed on TissueScan Cancer Survey Panels (CSRT101, OriGene, Rockville, MD, USA) and TissueScan Prostate Cancer quantitative PCR Panels (HPRT502, OriGene) using an ABI Prism 7500 thermocycler (Applied Biosystems Inc., Foster City, CA, USA).
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products